undamentalytics Newsletter
Sign in

Bunge Global (BG) stock

Add to watchlist

Add holding +

NYSE: BG NYSE Agricultural Products & Services Next results ~February 3, 2027

C+ Fundamentals grade

Bunge Global SA is an agribusiness that buys, stores, processes and sells agricultural commodities. According to its filing, it holds agricultural commodity inventories—described as readily marketable inventories—and enters physically settled forward contracts to purchase and sell crops. Its activities include grain merchandising, oilseed and vegetable oil operations, and milling, carried out through subsidiaries such as Bunge Oils and Bunge Milling.

The company earns money chiefly by trading and processing these commodities, with revenue recorded as net sales; the value of its inventories and forward contracts is marked to market, drawing on inputs such as public exchange quotes for commodity futures.

Its operations span several regions, with the filing noting activity in Brazil, North America and Europe, and identifying a Grain Merchandising reporting unit among its businesses. Formerly Bunge Limited, it became Bunge Global SA, a Swiss-incorporated company, through a 2023 merger. In 2023 it agreed to combine with Viterra Limited, an acquisition reflected in its 2025 accounts, including goodwill and allowances recognised on completion.

Based on Bunge Global's 10-K filed February 19, 2026.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$130

Valuation models combined (4)

Base case. Range ~$87–$180. Weighted average of 4 models (growth cash-flow model, forward price-to-earnings vs peers, residual income, justified price-to-book), the growth cash-flow model counting double.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Bunge Global valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders1 buying, 2 selling2 purchases and 3 sales by directors and officers, last 12 monthsInsider trades
  • Funds397 adding, 327 cuttingOf 68 active managers that changed their stake, 38 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Bunge Global files

10-Q filed October 29: Bunge Global

Bunge Global generated $93.5bn in revenue over the twelve months to September 2026, a 55.5% increase on the year before, though this marks a slowdown from the 80.5% growth recorded a quarter earlier. Among the 16 agricultural products and services companies we track, that pace of expansion ranks second. Free-cash-flow margin remained unchanged at -2.8%. Meanwhile, the diluted share count has climbed 28.6% year on year, diluting existing holders in the process. On valuation, our combined model puts fair value at $162 a share, well above the current share price of $97.61.

Source: 10-Q filed October 29, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where Bunge Global stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $91.8bn, up 80.5% on a year earlier, faster than 56.9% a quarter earlier. That growth ranks 24 of 931 among all the companies we cover. Free-cash-flow margin held at -0.8%. The diluted share count is up 42.6% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 1 of our 4 financial-health checks. Our valuation models combined value is $135 a share, against a share price of $103.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 3, 2027 (estimated)

Bunge Global's trailing-twelve-month revenue grew 55.5% year on year, with a free-cash-flow margin of -2.8%. Where it stands out: revenue growth of 55.5% ranks 2 of 20 agricultural products & services companies we cover. Where it lags: change in growth rate of -25.0pp ranks 19 of 20 agricultural products & services companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 136.3% while net income fell 12.4%: a 124pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 55.5% over the last 12 months, against a median of -0.8% for agricultural products & services companies we cover.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Growth slowing. The growth rate is 25.0 points lower than a quarter earlier.
  • Burning cash. Free cash flow was -2.8% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 28.6% in a year.
  • Weak cash conversion. Free cash flow was -229% of net income over the last 12 months.
  • Below peers: gross margin. Gross margin of 5.1% ranks 16 of 19 agricultural products & services companies we cover (median 11.4%).
  • Short interest rising. Shares sold short rose 17% in a month to 5.9% of tradable shares.

Latest results: FY2026 Q3

Filed October 29, 2026
Earnings per share
$2.56 against an average estimate of $2.43: beat by 5.6%
Revenue
$23.80bn, up 7.4% on a year earlier
Share reaction
-4.1% in the first session after the results on October 29, 2026, against -2.1% for the S&P 500
Guidance given
adjusted Net income per share from continuing operations - diluted $9.25 to $9.75 (full-year 2026); adjusted annual effective tax rate 23% to 25% (2026)
Next report
October 29, 2026; average EPS estimate $3.23

Bunge Global's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-2.5%
  • 1 week-7.8%
  • 1 month-11.7%
  • This year+7.7%
  • 1 year+2.2%
  • 5 years+17.8%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$93.5B
Net margin
1.2%
EPS (TTM, diluted)
$5.93

Growth

Revenue growth
+55.5%
Change in growth rate
−25.0 pts
Share count change
+28.6%

Cash

Free cash flow (TTM)
-$2.7B
FCF margin
-2.8%
Stock pay % of revenue
0.1%

Earnings

Last results
October 29, 2026
Next results (est.)
February 3, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Guidance
  3. Leadership
  4. Announcement
  5. Leadership
  6. Announcement
  7. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Bunge Global valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Bunge Global as an operating company, with every model that fits that kind of business. Cost of equity 7%: the 10-year Treasury yield (4.9%) plus a beta of 0.45 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$87 ~$40–$110 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$120 ~$99–$160 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$160 ~$100–$250 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$180 ~$140–$240 Included
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: earnings are positive: price-to-earnings is the better measure
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$480 ~$370–$610 Left out: out of range vs price (5.06x)
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$130 ~$87–$180 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Bunge Global with Agricultural Products & Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20212022202320242025Now
Share price$82.08$89.70$93.10$73.79$87.49$94.22
Market value$12.5bn$13.7bn$14.0bn$10.5bn$14.6bn$18.4bn
+ Net debt (− = net cash)−$902m$3.5bn$2.3bn$2.9bn$12.9bn$16.2bn
Enterprise value$11.6bn$17.3bn$16.3bn$13.4bn$27.5bn$34.6bn
Multiples
Price / sales 0.2x0.2x0.2x0.2x0.2x0.2x
Price / earnings 6.0x8.5x6.3x9.2x17.8x15.9x
Price / free cash flow ——6.4x20.0x——
EV / EBITDA ——————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $9.53 +26% $98.1bn +40%
Next $11.20 +18% $96.0bn −2%

Next year's EPS estimate has moved −0.5% in 90 days, across 6 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.6% on 90 days ago. In the last 30 days, 0 analysts raised Bunge Global's forecast and 2 cut it.

Consensus EPS forecast Bunge Global, last 90 days
$9.50 $10.00 $10.50 $11.00 $11.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $9.59 Current fiscal year, 60 days ago: $9.64 Current fiscal year, 30 days ago: $9.61 Current fiscal year, 7 days ago: $9.51 Current fiscal year, Now: $9.53 $9.53 Next fiscal year, 90 days ago: $11.26 Next fiscal year, 60 days ago: $11.34 Next fiscal year, 30 days ago: $11.26 Next fiscal year, 7 days ago: $11.23 Next fiscal year, Now: $11.20 $11.20

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $9.59$11.26
60 days ago $9.64$11.34
30 days ago $9.61$11.26
7 days ago $9.51$11.23
Now $9.53$11.20

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $2.43 $2.56 +5.6%
Jun 2026 $1.94 $2.00 +2.9%
Mar 2026 $0.87 $1.83 +109.4%
Dec 2025 $1.82 $1.99 +9.6%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 29, 2026
  • Adjusted Net income per share from continuing operations - diluted full-year 2026 $9.25 to $9.75 Non-GAAP Maintained
    “Taking into account third quarter results, the current margin and macro environment and forward curves, Bunge continues to expect full-year 2026 adjusted EPS in the range of $9.25 to $9.75.” source
  • Adjusted annual effective tax rate 2026 23% to 25% Non-GAAP Narrowed
    “An adjusted annual effective tax rate in the range of 23% to 25% compared to its previous range of 22% to 26%” source
  • Net interest expense 2026 $640m to $670m Raised
    “Net interest expense in the range of $640 to $670 million compared to its previous range of $620 to $660 million” source
  • Capital expenditures 2026 $1.5bn to $1.7bn Maintained vs 1.5bn to 1.7bn
    “Capital expenditures toward the higher end of the $1.5 to $1.7 billion range” source
  • Depreciation and amortization 2026 about $975m Maintained vs about 975m
    “Depreciation and amortization of approximately $975 million” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

9 analysts, Oct 2026
Buy889%
Hold111%
Sell00%

Monthly trend

  1. Oct 20263519
  2. Sep 20263519
  3. Aug 20263519
  4. Jul 20263519

Counts of recommendations published by analysts covering Bunge Global, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
5.9%
of tradable shares
Days to cover
4.14
at average volume
Short interest, 1 month
+17%
to October 15, 2026
Held by institutions
81%
of shares
Held by insiders
18.4%
of shares
Employees
34,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +2.2%

$92.23 on October 31, 2025 to $94.22

ThenNowEffect
Revenue (last 12 months) $50.9bn $91.8bn +80.5%
Net margin 2.7% 1.1% −59.5%
P/E multiple 9.2x 18.4x +99.3%
Share count 138m 196m −29.9%

Biggest factor: net margin.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
BG+46%+9%+4%−21%+19%+8%
Industry peers (median)+1%−26%−19%+1%−13%−9%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
BG58%75%42%33%58%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
BG−19%−35%−15%−32%−16%−28%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 61% from February 6, 2018 to March 18, 2020. Getting back needed a 153% gain, reached on February 8, 2021, 327 days after the low.

Price behaviour

52-week range
$86.97 – $130.59
From 52-week high
−27.8%
vs 50-day average
−14.5%
vs 200-day average
−18.9%
Volatility (1 year)
30%
Beta vs S&P 500
-0.14

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
3 up, 9 down
typical move ±4.7%
After a week
4 up, 7 down
typical move ±5.7%
After a month
6 up, 5 down
typical move ±4.3%
Results releasedNext dayS&P 500 next day5 days21 days
October 29, 2026 −4.1% −2.1% — —
July 29, 2026 −10.5% +0.1% −9.2% −4.3%
April 29, 2026 +0.6% +1.0% −0.2% −1.8%
February 4, 2026 −2.5% −1.7% +4.4% +0.4%
November 5, 2025 +0.9% −0.7% +2.6% +0.4%
July 30, 2025 +4.5% −0.5% +6.1% +11.8%
May 7, 2025 −2.4% +1.1% +4.8% −3.8%
February 5, 2025 −7.6% +0.8% −7.9% +1.8%
October 30, 2024 −4.3% −2.3% −2.4% +2.9%
July 31, 2024 −10.0% +0.2% −16.5% −11.2%
April 24, 2024 −5.1% −0.4% −7.9% −6.0%
February 7, 2024 −3.9% +0.9% −0.6% +3.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Bunge Global in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Bunge Global
$40B $60B $80B $100B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $59.5B Revenue (TTM), FY24 Q1: $57.6B Revenue (TTM), FY24 Q2: $55.8B Revenue (TTM), FY24 Q3: $54.5B Revenue (TTM), FY24 Q4: $53.1B Revenue (TTM), FY25 Q1: $51.3B Revenue (TTM), FY25 Q2: $50.9B Revenue (TTM), FY25 Q3: $60.1B Revenue (TTM), FY25 Q4: $70.3B Revenue (TTM), FY26 Q1: $80.5B Revenue (TTM), FY26 Q2: $91.8B Revenue (TTM), FY26 Q3: $93.5B $93.5B

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $59.5B
FY24 Q1 $57.6B
FY24 Q2 $55.8B
FY24 Q3 $54.5B
FY24 Q4 $53.1B
FY25 Q1 $51.3B
FY25 Q2 $50.9B
FY25 Q3 $60.1B
FY25 Q4 $70.3B
FY26 Q1 $80.5B
FY26 Q2 $91.8B
FY26 Q3 $93.5B
Revenue growth, TTM YoY Bunge Global
-50% 0% 50% 100% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -11.4% Revenue growth, TTM YoY, FY24 Q1: -13.6% Revenue growth, TTM YoY, FY24 Q2: -12.5% Revenue growth, TTM YoY, FY24 Q3: -11.0% Revenue growth, TTM YoY, FY24 Q4: -10.8% Revenue growth, TTM YoY, FY25 Q1: -10.9% Revenue growth, TTM YoY, FY25 Q2: -8.9% Revenue growth, TTM YoY, FY25 Q3: 10.3% Revenue growth, TTM YoY, FY25 Q4: 32.4% Revenue growth, TTM YoY, FY26 Q1: 56.9% Revenue growth, TTM YoY, FY26 Q2: 80.5% Revenue growth, TTM YoY, FY26 Q3: 55.5% 55.5%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -11.4%
FY24 Q1 -13.6%
FY24 Q2 -12.5%
FY24 Q3 -11.0%
FY24 Q4 -10.8%
FY25 Q1 -10.9%
FY25 Q2 -8.9%
FY25 Q3 10.3%
FY25 Q4 32.4%
FY26 Q1 56.9%
FY26 Q2 80.5%
FY26 Q3 55.5%
FCF margin (TTM) Bunge Global
-4% -2% 0% 2% 4% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 3.7% FCF margin (TTM), FY24 Q1: 3.8% FCF margin (TTM), FY24 Q2: 2.2% FCF margin (TTM), FY24 Q3: 2.0% FCF margin (TTM), FY24 Q4: 1.0% FCF margin (TTM), FY25 Q1: -1.6% FCF margin (TTM), FY25 Q2: -1.1% FCF margin (TTM), FY25 Q3: -1.9% FCF margin (TTM), FY25 Q4: -1.2% FCF margin (TTM), FY26 Q1: -1.4% FCF margin (TTM), FY26 Q2: -0.8% FCF margin (TTM), FY26 Q3: -2.8% -2.8%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 3.7%
FY24 Q1 3.8%
FY24 Q2 2.2%
FY24 Q3 2.0%
FY24 Q4 1.0%
FY25 Q1 -1.6%
FY25 Q2 -1.1%
FY25 Q3 -1.9%
FY25 Q4 -1.2%
FY26 Q1 -1.4%
FY26 Q2 -0.8%
FY26 Q3 -2.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 59.2 67.2 59.5 53.1 70.3 93.5
Gross profit 3.4 3.7 4.8 3.4 3.4 4.8
Net income 2.1 1.6 2.2 1.1 0.8 1.2
Diluted EPS $13.64 $10.51 $14.87 $7.99 $4.91 $5.93
Growth (year on year)
Revenue — +13.7% −11.4% −10.8% +32.4% +55.5%
Net income — −22.5% +39.3% −49.3% −28.2% −12.4%
Diluted EPS — −22.9% +41.5% −46.3% −38.5% −31.9%
Margins
Gross margin 5.7% 5.5% 8.1% 6.4% 4.8% 5.1%
Net margin 3.5% 2.4% 3.8% 2.1% 1.2% 1.2%
Free-cash-flow margin −5.6% −9.1% 3.7% 1.0% −1.2% −2.8%
Cash flow
Cash from operations −2.9 −5.5 3.3 1.9 0.8 −1.0
Capital spending 0.4 0.6 1.1 1.4 1.7 1.7
Free cash flow −3.3 −6.1 2.2 0.5 −0.9 −2.7
Stock-based pay 0.1 0.1 0.1 0.1 0.1 0.1
Free cash flow after stock pay −3.4 −6.2 2.1 0.5 −1.0 −2.7
Balance sheet
Cash 0.9 1.1 2.6 3.3 1.1 0.5
Total debt 0.0 4.7 4.9 6.2 14.1 16.7
Net debt (negative = net cash) −0.9 3.5 2.3 2.9 12.9 16.2
Diluted shares 152m 153m 151m 142m 166m 195m
Returned to shareholders
Dividends 0.3 0.3 0.4 0.4 0.5 0.5
Buybacks 0.1 0.2 0.6 1.1 0.6 —
Total returned 0.4 0.5 1.0 1.5 1.0 0.5

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 4 checks passed · September 30, 2026
What it owns · $49.7bn
Short-term assets $29.2bnLonger-term assets $20.4bn
What it owes, and who funded it · $35.7bn
Short-term liabilities $19.4bnShareholders' equity $16.3bn
  • Short-term assets cover short-term liabilities $29.2bn of assets due within a year against $19.4bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $524m of cash against $16.7bn of debt.
  • Debt below 40% of shareholders' equity Debt is 103% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$955m of operating cash flow against $16.7bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Bunge Global's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$549M
Returned to shareholders
-21%
of free cash flow
Buybacks, last 3 fiscal years
$2.3B
Diluted share count
+28.6%
year over year
Total shareholder yield
3.0%
dividends 3.0% + buybacks 0.0% of market value
Dividend payout ratio
47%
of net income paid out
Sales & admin spending
2.5%
of revenue
Days sales outstanding
16 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in agricultural products & services
Last 12 months unless stated BG ADM CHSCL ANDE INGR DAR Median
Revenue, last 12 months $93.5bn $82.1bn $37.4bn $10.9bn $7.2bn $6.5bn $149m
Revenue growth, last 12 months 55.5% −0.8% 3.8% −5.2% −1.4% 14.9% −1.1%
Revenue growth, 3-year average 15.1% −6.3% −8.9% −13.3% −4.2% −2.5% −0.1%
Revenue growth, latest quarter 7.4% 7.2% 18.6% −1.2% 0.9% 16.4% 6.8%
Gross margin 5.1% 6.9% 3.1% 7.2% 23.7% 26.3% 17.6%
Operating margin — — 0.1% — 11.9% 14.5% −5.9%
Operating margin, 3-year average — — 0.7% — 12.2% 9.9% 2.8%
Net margin 1.2% 2.2% 1.5% 1.6% 8.2% 9.1% −0.2%
Cash from operations / revenue −1.0% 3.4% 3.9% 2.9% 11.2% 20.6% 3.2%
Free-cash-flow margin −2.8% 2.0% 2.5% 0.5% 4.9% 12.6% 2.3%
Free-cash-flow margin, 3-year average −0.9% 3.5% 1.2% 2.1% 9.7% 8.2% 3.0%
Stock pay / revenue 0.1% 0.2% — 0.1% 0.5% 0.6% 0.7%
Change in share count 28.6% 0.3% — −0.1% −2.5% 0.5% 2.3%

Median of all 20 companies we cover in agricultural products & services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

20 agricultural products & services companies
Measure Company Peer median Rank
Revenue growth Growth 55.5% -0.8% 2 of 20
Change in growth rate Growth -25.0pp -0.5pp 19 of 20
Gross margin Profitability 5.1% 11.4% 16 of 19
Net margin Profitability 1.2% 0.1% 9 of 20
Free-cash-flow margin Cash generation -2.8% 2.5% 14 of 20
Stock pay as % of revenue Cash generation 0.1% 0.8% 2 of 17
Long-term debt as % of assets Balance sheet 18.0% 16.2% 11 of 18
Change in share count Balance sheet 28.6% 2.4% 12 of 17
Days sales outstanding Balance sheet 16 days 56 days 2 of 15

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Soybean Processing and Refining $36.3B 51.6% ▲ 13.7%
Grain Merchandising $16.6B 23.6% ▲ 94.7%
Softseed Processing and Refining $11.3B 16.0% ▲ 61.9%
Other Oilseeds Processing and Refining $4.6B 6.6% ▲ 11.6%
Milling Products $1.5B 2.2% ▼ 0.6%
Other Products $3M 0.0% 0.0%
Geography
Region Revenue Share YoY
Segment Geographical Groups of Countries Group Three $30.5B 43.3% ▲ 30.6%
United States $15.6B 22.2% ▲ 10.2%
Switzerland $15.6B 22.2% ▲ 9.5%
Netherlands $8.6B 12.2% ▲ 548.5%

From Bunge Global's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$19.6B
Institutions reporting
731
Shares held vs prior quarter
▲ 1.0%
Positions opened / closed
109 / 85

Top buyers and sellers, Q2 2026: 397 institutions bought and 327 sold ; the biggest buyer was Bank Of New York Mellon Corp (+1.2M shares) and the biggest seller British Columbia Investment Management Corp (−2.4M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Glencore PLC $3.5B 32.8M 17.9% 0.0%
Canada Pension Plan Investment Board $2.8B 26.2M 14.3% 0.0%
Capital World Investors $2.1B 19.4M 10.6% ▼ 3.8%
Blackrock, Inc. $1.6B 15.3M 8.3% ▲ 4.2%
Vanguard Capital Management LLC $1B 9.5M 5.2% ▲ 0.7%
Vanguard Portfolio Management LLC $759M 7.1M 3.9% ▼ 0.1%
State Street Corp $748M 7.0M 3.8% ▼ 0.4%
Geode Capital Management, LLC $388M 3.6M 2.0% ▲ 2.9%
Fil Ltd $363M 3.4M 1.9% ▲ 16.9%
FMR LLC $330M 3.1M 1.7% ▼ 5.4%
Invesco Ltd. $293M 2.7M 1.5% ▼ 0.9%
Bank Of New York Mellon Corp $267M 2.5M 1.4% ▲ 95.1%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Bunge Global's complete shareholder register. Values are as reported by the filers ; 3 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $689,050 2 trades by 1 insider, last 12 months Insider sales History → $2.7M 3 trades by 2 insiders · 0% under pre-set plans
Net ▼ $2M net selling
Insider Date Trade Shares Price Value
Mahoney Christopher Director August 4, 2026 Buy 1,500 $107.60 $161,400
Mahoney Christopher Director July 31, 2026 Buy 5,000 $105.53 $527,650
Garros Julio Chief Operating Officer February 11, 2026 Sell 2,831 $119.00 $336,889
Dimopoulos Christos Executive VP, Global Markets November 21, 2025 Sell 20,000 $94.37 $1.9M
Dimopoulos Christos Executive VP, Global Markets November 21, 2025 Sell 5,300 $94.38 $500,226

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around February 3, 2027 estimated from the company's past filing pattern, not announced

  • October 29, 2026
  • July 29, 2026
  • April 29, 2026
  • February 4, 2026
  • November 5, 2025
  • July 30, 2025

Recent SEC filings

Data status

When each part of this page on Bunge Global was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Bunge Global in brief

What does Bunge Global do?
Bunge Global is a US-listed company in the agricultural products & services industry. Its financial year ends in December.
What is Bunge Global's stock ticker?
Bunge Global trades under the ticker BG on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Bunge Global's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Bunge Global reported revenue of $93.5B, 55.5% higher than a year earlier, according to its SEC filings.
What is Bunge Global's free cash flow?
Bunge Global's free-cash-flow margin is -2.8% of revenue over the trailing twelve months, ranking 14 of the 20 agricultural products & services companies we cover.
Who are Bunge Global's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Glencore PLC, Canada Pension Plan Investment Board and Capital World Investors. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Bunge Global's market cap?
On November 2, 2026, Bunge Global's market capitalisation was about $18.4B, with a price-to-earnings ratio of 15.9 and net debt of $16.2B. Market figures come from third-party market data and may be delayed.
Does Bunge Global pay a dividend?
Yes: Bunge Global paid $549M in dividends over the trailing twelve months, a dividend yield of 3.00% and a payout ratio of 47.4%.
How much debt does Bunge Global have?
Bunge Global's debt-to-equity ratio is 102.8%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
Who are Bunge Global's competitors?
In our Agricultural Products & Services peer group, the companies closest to Bunge Global are Archer Daniels Midland, CHS Inc, Andersons, Inc., Ingredion Inc and Darling Ingredients Inc. The side-by-side comparison below sets their revenue, margins and growth against Bunge Global's.
Are insiders buying or selling Bunge Global stock?
Over the last 12 months, Bunge Global's directors and officers reported 2 open-market purchases and 3 sales on Form 4. The insider trading page charts every trade.
When is Bunge Global's next earnings date?
Around February 3, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Bunge Global announces its own schedule.